INVION LIMITED - Announcements

1.04%

9.5¢

Market Cap $8.114M

Healthcare Biotechnology

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

IVX	Appendix 4D and Financial Report for half year to 31 Dec 17	PRICE SENSITIVE	28/02/18	332.83KB	Share
IVX	Rights Issue Information Booklet	PRICE SENSITIVE	12/02/18	3.32MB	Share
IVX	Invion announces underwritten Right Issue	PRICE SENSITIVE	12/02/18	106.04KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	08/02/18	491.73KB	Share
IVX	Appendix 4C - December 2017 Quarter	PRICE SENSITIVE	29/01/18	178.51KB	Share
IVX	Appointment of Non Executive Director and Chairman	PRICE SENSITIVE	01/12/17	86.08KB	Share
IVX	AGM - Withdrawal of Resolution prior to Meeting	PRICE SENSITIVE	30/11/17	83.24KB	Share
IVX	AGM Notice of Meeting And Proxy Form	PRICE SENSITIVE	30/10/17	2.06MB	Share
IVX	Appendix 4C - cashflow statement for the September quarter	PRICE SENSITIVE	27/10/17	178.92KB	Share
IVX	Appendix 4G - Key to governance disclosures	PRICE SENSITIVE	27/10/17	112.32KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	22/09/17	486.17KB	Share
IVX	Strategic Transaction Update	PRICE SENSITIVE	05/09/17	240.49KB	Share
IVX	Trading Halt	PRICE SENSITIVE	01/09/17	326.3KB	Share
IVX	Appendix 4E and Full Year Statutory Accounts	PRICE SENSITIVE	31/08/17	942.87KB	Share
IVX	Invion announces strategic transaction	PRICE SENSITIVE	31/08/17	96.97KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	102.84KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	155.94KB	Share
IVX	Invion announces strategic alliance	PRICE SENSITIVE	18/04/17	94.2KB	Share
IVX	Appendix 4D and Financial Report for half year to 31 Dec 16	PRICE SENSITIVE	27/02/17	842.22KB	Share
IVX	Appendix 4C December quarter	PRICE SENSITIVE	30/01/17	176.75KB	Share
IVX	Appendix 4C for the September quarter-IVX.AX	PRICE SENSITIVE	31/10/16	176.99KB	Share
IVX	Receipt of R&T tax rebate-IVX.AX	PRICE SENSITIVE	12/09/16	246.73KB	Share
IVX	App 4E, Annual and Financial Report FY2016-IVX.AX	PRICE SENSITIVE	30/08/16	929.47KB	Share
IVX	Response to ASX Appendix 4C query-IVX.AX	PRICE SENSITIVE	08/08/16	630.18KB	Share
IVX	Appendix 4C - quarterly-IVX.AX	PRICE SENSITIVE	29/07/16	238.62KB	Share
IVX	Phase 2 data presented to American Thoracic Society-IVX.AX	PRICE SENSITIVE	20/05/16	256.11KB	Share
IVX	Response to ASX Appendix 4C Query-IVX.AX	PRICE SENSITIVE	09/05/16	360.01KB	Share
IVX	Appendix 4C - quarterly-IVX.AX	PRICE SENSITIVE	29/04/16	262.46KB	Share
IVX	End of Phase 2 Meeting for INV102 (nadolol)-IVX.AX	PRICE SENSITIVE	04/04/16	263.1KB	Share
IVX	Smoking cessation patent allowance and Operational update	PRICE SENSITIVE	10/03/16	254.66KB	Share
IVX	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	26/02/16	569.05KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/16	374.65KB	Share
IVX	Invion completes SPP and Placement	PRICE SENSITIVE	09/12/15	237.42KB	Share
IVX	Smoking cessation trial results of ongoing data analysis	PRICE SENSITIVE	17/11/15	239.02KB	Share
IVX	Invion announces Share Purchase Plan	PRICE SENSITIVE	10/11/15	230.95KB	Share
IVX	Litigation update - decision of High Court	PRICE SENSITIVE	04/11/15	108.89KB	Share
IVX	Completion of enrolment in INV102 phase II asthma study	PRICE SENSITIVE	02/11/15	231.52KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	252.26KB	Share
IVX	Receipt of R&D tax rebate and repayment of Metamor loan	PRICE SENSITIVE	09/10/15	229.39KB	Share
IVX	Invion - successful completion of P2 study of INV102	PRICE SENSITIVE	05/10/15	245.24KB	Share
IVX	Invion announces no secondary capital raise	PRICE SENSITIVE	07/09/15	227.63KB	Share
IVX	Invion completes placement to institutional US investor	PRICE SENSITIVE	01/09/15	263.25KB	Share
IVX	Appendix 4E and Financial Report for YE 30 June 15	PRICE SENSITIVE	31/08/15	1.18MB	Share
IVX	Trading Halt	PRICE SENSITIVE	28/08/15	224.65KB	Share
IVX	INV103 ala-Cpn10 clinical trial in lupus complete	PRICE SENSITIVE	17/08/15	284.78KB	Share
IVX	Response to ASX Appendix 4C Query	PRICE SENSITIVE	11/08/15	320.53KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	368.36KB	Share
IVX	Joint development and licensing agreement for Zafirlukast	PRICE SENSITIVE	27/07/15	292.84KB	Share
IVX	Response to Price Query	PRICE SENSITIVE	13/07/15	327.6KB	Share
IVX	Milestone update	PRICE SENSITIVE	03/07/15	236.37KB	Share
IVX	PhII smoking cessation - dosing complete analysis underway	PRICE SENSITIVE	29/06/15	346.96KB	Share
IVX	Oral nadolol data presented to American Thoracic Society	PRICE SENSITIVE	19/05/15	241.73KB	Share
IVX	Pre-IND status for inhaled INV102 (nadolol)	PRICE SENSITIVE	23/03/15	242.11KB	Share
IVX	Pre-IND status for inhaled INV102 (nadolol)	PRICE SENSITIVE	23/03/15	242.11KB	Share
IVX	Entitlment offer information booklet	PRICE SENSITIVE	20/03/15	2.63MB	Share
IVX	Reinstatement to Official Quotation	PRICE SENSITIVE	20/03/15	48.11KB	Share
IVX	Invion announces $5M Placement and Rights Issue	PRICE SENSITIVE	20/03/15	243.49KB	Share
IVX	Suspension from Official Quotation	PRICE SENSITIVE	16/03/15	261.41KB	Share
IVX	Trading Halt	PRICE SENSITIVE	12/03/15	198.96KB	Share
IVX	Appendix 4D and Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/15	344.38KB	Share
IVX	Completion of enrolment in Ph II smoking cessation trial	PRICE SENSITIVE	02/02/15	143.88KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	365.05KB	Share
IVX	Invion announces interim data in smoking cessation trial	PRICE SENSITIVE	19/01/15	238.68KB	Share
IVX	Receipt of R&D tax cash rebate	PRICE SENSITIVE	27/11/14	218KB	Share
IVX	Funding Agreement with Australian Special Opportunity Fund	PRICE SENSITIVE	10/11/14	268.7KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	376.8KB	Share
IVX	Update on 3M collaboration for inhaled INV102 (nadolol)	PRICE SENSITIVE	24/09/14	250.98KB	Share
IVX	Phase 2 asthma trial interim blinded data	PRICE SENSITIVE	23/09/14	258.43KB	Share
IVX	Lupus clinical trial update	PRICE SENSITIVE	08/09/14	240.23KB	Share
IVX	Appendix 4E and Full Year Statutory Accounts	PRICE SENSITIVE	28/08/14	844.23KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14	383.48KB	Share
IVX	Litigation update - orders on interest and costs	PRICE SENSITIVE	23/06/14	211.79KB	Share
IVX	Litigation update - Receipt of judgment	PRICE SENSITIVE	04/06/14	227.8KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/14	363.08KB	Share
IVX	Litigation update	PRICE SENSITIVE	14/03/14	213.75KB	Share
IVX	Rights Issue Information Booklet	PRICE SENSITIVE	26/02/14	2.01MB	Share
IVX	Invion announces Rights Issue Entitlement Offer	PRICE SENSITIVE	26/02/14	248.73KB	Share
IVX	Appendix 4D and Half Yearly Accounts	PRICE SENSITIVE	25/02/14	476.96KB	Share
IVX	Invion completes Placement and announces Rights Issue	PRICE SENSITIVE	21/02/14	224.16KB	Share
IVX	Trading Halt	PRICE SENSITIVE	19/02/14	209.89KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	358.5KB	Share
IVX	FDA lifts hold on smoking cessation trial	PRICE SENSITIVE	29/01/14	222.3KB	Share
IVX	Smoking cessation study hold	PRICE SENSITIVE	20/12/13	242.49KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/13	234.34KB	Share
IVX	Invion announces in-licence agreement	PRICE SENSITIVE	28/10/13	261.54KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	22/10/13	263.97KB	Share
IVX	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	23/08/13	1.17MB	Share
IVX	Invion to receive up to 1.4M tax rebate	PRICE SENSITIVE	01/08/13	241.03KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/13	384.89KB	Share
IVX	Commencement of chronic bronchitis clinical trial	PRICE SENSITIVE	22/07/13	329.63KB	Share
IVX	Commencement of phase II lupus trial	PRICE SENSITIVE	18/07/13	328.77KB	Share
IVX	Invion announces $2M placement	PRICE SENSITIVE	11/06/13	270.49KB	Share
IVX	Trading Halt	PRICE SENSITIVE	06/06/13	284.34KB	Share
IVX	Litigation update confidential settlement reached	PRICE SENSITIVE	21/05/13	198.36KB	Share
IVX	Appointment of Managing Director and CEO	PRICE SENSITIVE	06/05/13	262.38KB	Share
IVX	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/13	401.2KB	Share
IVX	Invion announces submission of lupus IND	PRICE SENSITIVE	24/04/13	264.45KB	Share
IVX	Invion announces Share Purchase Plan	PRICE SENSITIVE	28/03/13	250.29KB	Share
IVX	Appendix 4D and Half-year Financial Report	PRICE SENSITIVE	19/02/13	691.15KB	Share
IVX	Update - Litigation	PRICE SENSITIVE	07/02/13	290.41KB	Share

IVX Appendix 4D and Financial Report for half year to 31 Dec 17
28/02/18	PRICE SENSITIVE	332.83KB	Share
IVX Rights Issue Information Booklet
12/02/18	PRICE SENSITIVE	3.32MB	Share
IVX Invion announces underwritten Right Issue
12/02/18	PRICE SENSITIVE	106.04KB	Share
IVX Response to ASX Price Query
08/02/18	PRICE SENSITIVE	491.73KB	Share
IVX Appendix 4C - December 2017 Quarter
29/01/18	PRICE SENSITIVE	178.51KB	Share
IVX Appointment of Non Executive Director and Chairman
01/12/17	PRICE SENSITIVE	86.08KB	Share
IVX AGM - Withdrawal of Resolution prior to Meeting
30/11/17	PRICE SENSITIVE	83.24KB	Share
IVX AGM Notice of Meeting And Proxy Form
30/10/17	PRICE SENSITIVE	2.06MB	Share
IVX Appendix 4C - cashflow statement for the September quarter
27/10/17	PRICE SENSITIVE	178.92KB	Share
IVX Appendix 4G - Key to governance disclosures
27/10/17	PRICE SENSITIVE	112.32KB	Share
IVX Response to ASX Price Query
22/09/17	PRICE SENSITIVE	486.17KB	Share
IVX Strategic Transaction Update
05/09/17	PRICE SENSITIVE	240.49KB	Share
IVX Trading Halt
01/09/17	PRICE SENSITIVE	326.3KB	Share
IVX Appendix 4E and Full Year Statutory Accounts
31/08/17	PRICE SENSITIVE	942.87KB	Share
IVX Invion announces strategic transaction
31/08/17	PRICE SENSITIVE	96.97KB	Share
IVX Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	102.84KB	Share
IVX Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	155.94KB	Share
IVX Invion announces strategic alliance
18/04/17	PRICE SENSITIVE	94.2KB	Share
IVX Appendix 4D and Financial Report for half year to 31 Dec 16
27/02/17	PRICE SENSITIVE	842.22KB	Share
IVX Appendix 4C December quarter
30/01/17	PRICE SENSITIVE	176.75KB	Share
IVX Appendix 4C for the September quarter-IVX.AX
31/10/16	PRICE SENSITIVE	176.99KB	Share
IVX Receipt of R&T tax rebate-IVX.AX
12/09/16	PRICE SENSITIVE	246.73KB	Share
IVX App 4E, Annual and Financial Report FY2016-IVX.AX
30/08/16	PRICE SENSITIVE	929.47KB	Share
IVX Response to ASX Appendix 4C query-IVX.AX
08/08/16	PRICE SENSITIVE	630.18KB	Share
IVX Appendix 4C - quarterly-IVX.AX
29/07/16	PRICE SENSITIVE	238.62KB	Share
IVX Phase 2 data presented to American Thoracic Society-IVX.AX
20/05/16	PRICE SENSITIVE	256.11KB	Share
IVX Response to ASX Appendix 4C Query-IVX.AX
09/05/16	PRICE SENSITIVE	360.01KB	Share
IVX Appendix 4C - quarterly-IVX.AX
29/04/16	PRICE SENSITIVE	262.46KB	Share
IVX End of Phase 2 Meeting for INV102 (nadolol)-IVX.AX
04/04/16	PRICE SENSITIVE	263.1KB	Share
IVX Smoking cessation patent allowance and Operational update
10/03/16	PRICE SENSITIVE	254.66KB	Share
IVX Appendix 4D and Half Year Accounts
26/02/16	PRICE SENSITIVE	569.05KB	Share
IVX Appendix 4C - quarterly
28/01/16	PRICE SENSITIVE	374.65KB	Share
IVX Invion completes SPP and Placement
09/12/15	PRICE SENSITIVE	237.42KB	Share
IVX Smoking cessation trial results of ongoing data analysis
17/11/15	PRICE SENSITIVE	239.02KB	Share
IVX Invion announces Share Purchase Plan
10/11/15	PRICE SENSITIVE	230.95KB	Share
IVX Litigation update - decision of High Court
04/11/15	PRICE SENSITIVE	108.89KB	Share
IVX Completion of enrolment in INV102 phase II asthma study
02/11/15	PRICE SENSITIVE	231.52KB	Share
IVX Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	252.26KB	Share
IVX Receipt of R&D tax rebate and repayment of Metamor loan
09/10/15	PRICE SENSITIVE	229.39KB	Share
IVX Invion - successful completion of P2 study of INV102
05/10/15	PRICE SENSITIVE	245.24KB	Share
IVX Invion announces no secondary capital raise
07/09/15	PRICE SENSITIVE	227.63KB	Share
IVX Invion completes placement to institutional US investor
01/09/15	PRICE SENSITIVE	263.25KB	Share
IVX Appendix 4E and Financial Report for YE 30 June 15
31/08/15	PRICE SENSITIVE	1.18MB	Share
IVX Trading Halt
28/08/15	PRICE SENSITIVE	224.65KB	Share
IVX INV103 ala-Cpn10 clinical trial in lupus complete
17/08/15	PRICE SENSITIVE	284.78KB	Share
IVX Response to ASX Appendix 4C Query
11/08/15	PRICE SENSITIVE	320.53KB	Share
IVX Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	368.36KB	Share
IVX Joint development and licensing agreement for Zafirlukast
27/07/15	PRICE SENSITIVE	292.84KB	Share
IVX Response to Price Query
13/07/15	PRICE SENSITIVE	327.6KB	Share
IVX Milestone update
03/07/15	PRICE SENSITIVE	236.37KB	Share
IVX PhII smoking cessation - dosing complete analysis underway
29/06/15	PRICE SENSITIVE	346.96KB	Share
IVX Oral nadolol data presented to American Thoracic Society
19/05/15	PRICE SENSITIVE	241.73KB	Share
IVX Pre-IND status for inhaled INV102 (nadolol)
23/03/15	PRICE SENSITIVE	242.11KB	Share
IVXPre-IND status for inhaled INV102 (nadolol)
23/03/15	PRICE SENSITIVE	242.11KB	Share
IVX Entitlment offer information booklet
20/03/15	PRICE SENSITIVE	2.63MB	Share
IVX Reinstatement to Official Quotation
20/03/15	PRICE SENSITIVE	48.11KB	Share
IVX Invion announces $5M Placement and Rights Issue
20/03/15	PRICE SENSITIVE	243.49KB	Share
IVX Suspension from Official Quotation
16/03/15	PRICE SENSITIVE	261.41KB	Share
IVX Trading Halt
12/03/15	PRICE SENSITIVE	198.96KB	Share
IVX Appendix 4D and Half Yearly Report and Accounts
26/02/15	PRICE SENSITIVE	344.38KB	Share
IVX Completion of enrolment in Ph II smoking cessation trial
02/02/15	PRICE SENSITIVE	143.88KB	Share
IVX Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	365.05KB	Share
IVX Invion announces interim data in smoking cessation trial
19/01/15	PRICE SENSITIVE	238.68KB	Share
IVX Receipt of R&D tax cash rebate
27/11/14	PRICE SENSITIVE	218KB	Share
IVX Funding Agreement with Australian Special Opportunity Fund
10/11/14	PRICE SENSITIVE	268.7KB	Share
IVX Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	376.8KB	Share
IVX Update on 3M collaboration for inhaled INV102 (nadolol)
24/09/14	PRICE SENSITIVE	250.98KB	Share
IVX Phase 2 asthma trial interim blinded data
23/09/14	PRICE SENSITIVE	258.43KB	Share
IVX Lupus clinical trial update
08/09/14	PRICE SENSITIVE	240.23KB	Share
IVX Appendix 4E and Full Year Statutory Accounts
28/08/14	PRICE SENSITIVE	844.23KB	Share
IVX Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE	383.48KB	Share
IVX Litigation update - orders on interest and costs
23/06/14	PRICE SENSITIVE	211.79KB	Share
IVXLitigation update - Receipt of judgment
04/06/14	PRICE SENSITIVE	227.8KB	Share
IVXAppendix 4C - quarterly
28/04/14	PRICE SENSITIVE	363.08KB	Share
IVXLitigation update
14/03/14	PRICE SENSITIVE	213.75KB	Share
IVXRights Issue Information Booklet
26/02/14	PRICE SENSITIVE	2.01MB	Share
IVXInvion announces Rights Issue Entitlement Offer
26/02/14	PRICE SENSITIVE	248.73KB	Share
IVXAppendix 4D and Half Yearly Accounts
25/02/14	PRICE SENSITIVE	476.96KB	Share
IVXInvion completes Placement and announces Rights Issue
21/02/14	PRICE SENSITIVE	224.16KB	Share
IVXTrading Halt
19/02/14	PRICE SENSITIVE	209.89KB	Share
IVXAppendix 4C - quarterly
31/01/14	PRICE SENSITIVE	358.5KB	Share
IVXFDA lifts hold on smoking cessation trial
29/01/14	PRICE SENSITIVE	222.3KB	Share
IVXSmoking cessation study hold
20/12/13	PRICE SENSITIVE	242.49KB	Share
IVXAppendix 4C - quarterly
31/10/13	PRICE SENSITIVE	234.34KB	Share
IVXInvion announces in-licence agreement
28/10/13	PRICE SENSITIVE	261.54KB	Share
IVXResponse to ASX Price Query
22/10/13	PRICE SENSITIVE	263.97KB	Share
IVXApp 4E / Full Year Statutory Accounts
23/08/13	PRICE SENSITIVE	1.17MB	Share
IVXInvion to receive up to 1.4M tax rebate
01/08/13	PRICE SENSITIVE	241.03KB	Share
IVXAppendix 4C - quarterly
31/07/13	PRICE SENSITIVE	384.89KB	Share
IVXCommencement of chronic bronchitis clinical trial
22/07/13	PRICE SENSITIVE	329.63KB	Share
IVXCommencement of phase II lupus trial
18/07/13	PRICE SENSITIVE	328.77KB	Share
IVXInvion announces $2M placement
11/06/13	PRICE SENSITIVE	270.49KB	Share
IVXTrading Halt
06/06/13	PRICE SENSITIVE	284.34KB	Share
IVXLitigation update confidential settlement reached
21/05/13	PRICE SENSITIVE	198.36KB	Share
IVXAppointment of Managing Director and CEO
06/05/13	PRICE SENSITIVE	262.38KB	Share
IVXAppendix 4C - quarterly
30/04/13	PRICE SENSITIVE	401.2KB	Share
IVXInvion announces submission of lupus IND
24/04/13	PRICE SENSITIVE	264.45KB	Share
IVXInvion announces Share Purchase Plan
28/03/13	PRICE SENSITIVE	250.29KB	Share
IVXAppendix 4D and Half-year Financial Report
19/02/13	PRICE SENSITIVE	691.15KB	Share
IVXUpdate - Litigation
07/02/13	PRICE SENSITIVE	290.41KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.5¢		Change -0.001(1.04%)		Mkt cap ! $8.114M

Open	High	Low	Value	Volume
9.6¢	9.6¢	9.5¢	$2.942K	30.75K

Buyers (Bids)

No.	Vol.	Price($)
2	66962	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.6¢	29244	1

View Market Depth

No.	Vol.	Price($)
2	66962	0.095
1	47000	0.094
2	33000	0.093
1	42667	0.092
2	31666	0.090

Price($)	Vol.	No.
0.096	29244	1
0.097	50000	1
0.099	146502	2
0.100	168957	3
0.105	38013	4

Last trade - 15.01pm 08/08/2025 (20 minute delay)

IVX (ASX) Chart

INVION LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available